AQSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Aquestive Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$3.83+0.05 (+1.32%)
Close on Oct 19, 2026
- Market cap
- $478.73M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Aquestive Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 15, 2026 | Oct 19, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 15, 2026 | Oct 15, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 13, 2026 | Oct 14, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 29, 2026 | Sep 29, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 23, 2026 | Sep 25, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 14, 2026 | Sep 17, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 10, 2026 | Aug 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2026 | Jun 10, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 13, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 10, 2026 | Apr 24, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 30, 2026 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 16, 2026 | Mar 20, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 4, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2026 | Mar 4, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 30, 2026 | Feb 2, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 9, 2026 | Jan 9, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 8, 2025 | Oct 8, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2025 | Oct 1, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2025 | Sep 8, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 4, 2025 | Sep 4, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2025 | Aug 15, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2025 | Aug 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 15, 2025 | Jul 15, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2025 | Jun 16, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2025 | Jun 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2025 | Jun 2, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 11, 2025 | Apr 25, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 1, 2025 | Apr 1, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2025 | Mar 10, 2025 | SEC EDGAR |